{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "2021", "item": "https://www.patentleaderboard.com/2021/"}, {"@type": "ListItem", "position": 3, "name": "Eli Lilly", "item": "https://www.patentleaderboard.com/2021/company/lilly"}, {"@type": "ListItem", "position": 4, "name": "Over Cabrera", "item": "https://www.patentleaderboard.com/2021/inventor/fl:ov_ln:cabrera-1"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
OC

Over Cabrera — 1 Patent in 2021

Eli Lilly: 1 patents #25 of 188Top 15%
Carmel, IN: #74 of 224 inventorsTop 35%
Indiana: #1,178 of 3,792 inventorsTop 35%
Overall (2021): #310,992 of 548,734Top 60%
1 Patents 2021

Issued Patents 2021

Showing 1–1 of 1 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11084861 GIP/GLP1 co-agonist compounds Milata Mary Abraham, Jorge Alsina-Fernandez, Robert Brown, Tamer Coskun, Robert Chadwick Cummins +5 more 2021-08-10 $2,040,565,000